Summary
- Current Price
- As of today, CMMB price is $2.48
- Current Price All-Time High
- CMMB price is currently -99.66% below its historical high of $736.00 set on
- Market Cap
- CMMB current market cap is $18M, up +35.11% over the past 365 days
- Revenue
- CMMB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CMMB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Chemomab Therapeutics Ltd. |
| Ticker | NASDAQ: CMMB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | chemomab.com |
| Employees | 12 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.48 | ||
| Price, 1D Change | - | |
| $18M | ||
| - | ||
| - | ||
| 1.68 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.42 | ||
| EPS, 1Y Change | +54.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ANCN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.42 | ||
| EPS Estimate | -$0.02 | N/A |
| EPS Est. Change | +98.59% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $2.48 | ||
| Price Target | $5.00 | - |
| Price Tgt. Change | +101.61% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.05 | -$3.12 | -6,143.80% | |
| -$0.08 | -$1.42 | -1,677.00% | |
| -$0.02 | N/A | +98.59% | |
| -$0.03 | N/A | +97.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -4.62% | ||
| -32.61% | ||
| +35.11% | ||
| -60.19% | ||
| 0.00% | ||
| 0.00% | ||
| +54.46% | ||
| +41.25% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.48 | ||
| $1.84 | ||
| $2.06 | ||
| $2.20 | ||
| $2.24 | ||
| $0.14 | ||
| 1.68 | ||
| $0.21 | ||
| 51.76 | ||
| 73.84% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.42 | ||
| $0.00 | ||
| - | ||
| -$9.64M | ||
| - | ||
| -$9.07M | ||
| - | ||
| -$9.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 9.08 | ||
| 9.08 | ||
| - | ||
| - | ||
| -5.20 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.09 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $12.33M | ||
| $10.37M | ||
| $13.81M | ||
| $13.42M | ||
| $1.48M | ||
| $1.48M | ||
| $0.00 | ||
| $0.00 | ||
| $485.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $9.07M | ||
| $9.64M | ||
| $0.00 | ||
| $3.76M | ||
| $70.60K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$11.22M | ||
| $5.43M | ||
| $7.21M | ||
| $3,000.00 | ||
| -$11.22M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | → | |
| Oppenheimer | → | |
| Maxim Group | → | |
| Oppenheimer | → | |
| Maxim Group | ||
| Oppenheimer | → | |
| Oppenheimer | → | |
| Roth MKM | ||
| Oppenheimer | → | |
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with CMMB
FAQ
- What is the ticker symbol for Chemomab Therapeutics Ltd.?
- The ticker symbol for Chemomab Therapeutics Ltd. is NASDAQ:CMMB
- Does Chemomab Therapeutics Ltd. pay dividends?
- No, Chemomab Therapeutics Ltd. does not pay dividends
- What sector is Chemomab Therapeutics Ltd. in?
- Chemomab Therapeutics Ltd. is in the Healthcare sector
- What industry is Chemomab Therapeutics Ltd. in?
- Chemomab Therapeutics Ltd. is in the Biotechnology industry
- What country is Chemomab Therapeutics Ltd. based in?
- Chemomab Therapeutics Ltd. is headquartered in Israel
- When did Chemomab Therapeutics Ltd. go public?
- Chemomab Therapeutics Ltd. initial public offering (IPO) was on February 12, 2019
- Is Chemomab Therapeutics Ltd. in the S&P 500?
- No, Chemomab Therapeutics Ltd. is not included in the S&P 500 index
- Is Chemomab Therapeutics Ltd. in the NASDAQ 100?
- No, Chemomab Therapeutics Ltd. is not included in the NASDAQ 100 index
- Is Chemomab Therapeutics Ltd. in the Dow Jones?
- No, Chemomab Therapeutics Ltd. is not included in the Dow Jones index
- When was Chemomab Therapeutics Ltd. last earnings report?
- Chemomab Therapeutics Ltd.'s most recent earnings report was on November 10, 2022
- When does Chemomab Therapeutics Ltd. report earnings?
- The date for Chemomab Therapeutics Ltd.'s next earnings report has not been announced yet
Data Sources & References
- CMMB Official Website www.chemomab.com
- CMMB Profile on Yahoo Finance finance.yahoo.com/quote/CMMB
- CMMB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cmmb